| Cardiac Fibrosis and Remodeling | Lifetime | 179 | TW 1 | 97.27 |
| Autophagy in Disease and Therapy | Lifetime | 587 | TW 4 | 96.44 |
| Chemotherapy-induced cardiotoxicity and mitigation | Lifetime | 197 | TW 1 | 95.87 |
| Traditional Chinese Medicine Analysis | Lifetime | 292 | TW 8 | 95.91 |
| Signaling Pathways in Disease | Lifetime | 443 | TW 4 | 95.68 |
| Sirtuins and Resveratrol in Medicine | Lifetime | 243 | TW 4 | 94.97 |
| Biochemical effects in animals | Lifetime | 775 | TW 8 | 95.49 |
| Cancer Mechanisms and Therapy | Lifetime | 814 | TW 13 | 92.82 |
| Advanced Glycation End Products research | Lifetime | 917 | TW 10 | 91.34 |
| Ginseng Biological Effects and Applications | Lifetime | 711 | TW 9 | 91.09 |
| Medicinal Plants and Bioactive Compounds | Lifetime | 321 | TW 16 | 86.57 |
| GDF15 and Related Biomarkers | Lifetime | 371 | TW 1 | 85.24 |
| Saffron Plant Research Studies | Lifetime | 250 | TW 4 | 84.79 |
| Bioactive natural compounds | Lifetime | 745 | TW 37 | 84.24 |
| Antioxidants, Aging, Portulaca oleracea | Lifetime | 98 | TW 3 | 79.62 |
| Medicinal Plant Pharmacodynamics Research | Lifetime | 611 | TW 10 | 75.22 |
| Hydrogen's biological and therapeutic effects | Lifetime | 746 | TW 9 | 74.25 |
| Flavonoids in Medical Research | Lifetime | 999 | TW 50 | 72.45 |
| Nigella sativa pharmacological applications | Lifetime | 821 | TW 2 | 65.04 |
| Andrographolide Research and Applications | Lifetime | 904 | TW 48 | 37.74 |
| Mesenchymal stem cell research | 2021-2025 | 159 | TW 2 | 93.99 |
| Autophagy in Disease and Therapy | 2021-2025 | 490 | TW 6 | 88.24 |
| Chemotherapy-induced cardiotoxicity and mitigation | 2021-2025 | 242 | TW 2 | 86.09 |
| Skin Protection and Aging | 2021-2025 | 359 | TW 8 | 86.09 |
| Cancer Treatment and Pharmacology | 2021-2025 | 858 | TW 6 | 85.07 |
| Genomics, phytochemicals, and oxidative stress | 2021-2025 | 421 | TW 6 | 80.19 |
| Cardiac Fibrosis and Remodeling | 2021-2025 | 332 | TW 3 | 78.61 |
| NF-κB Signaling Pathways | 2021-2025 | 107 | TW 4 | 74.82 |
| Traditional Chinese Medicine Analysis | 2021-2025 | 399 | TW 4 | 77.14 |
| Cancer Mechanisms and Therapy | 2021-2025 | 710 | TW 16 | 75.70 |
| Advanced Glycation End Products research | 2021-2025 | 555 | TW 9 | 68.68 |
| Bioactive natural compounds | 2021-2025 | 205 | TW 4 | 66.41 |
| Curcumin's Biomedical Applications | 2021-2025 | 653 | TW 9 | 65.72 |
| Telomeres, Telomerase, and Senescence | 2021-2025 | 698 | TW 2 | 65.90 |
| Cell death mechanisms and regulation | 2021-2025 | 379 | TW 16 | 63.53 |
| Cardiac Ischemia and Reperfusion | 2021-2025 | 738 | TW 8 | 64.65 |
| High Altitude and Hypoxia | 2021-2025 | 753 | TW 1 | 65.20 |
| Sirtuins and Resveratrol in Medicine | 2021-2025 | 747 | TW 11 | 59.23 |
| Medicinal Plants and Bioactive Compounds | 2021-2025 | 366 | TW 4 | 59.10 |
| FOXO transcription factor regulation | 2021-2025 | 220 | TW 2 | 55.82 |
| Heat shock proteins research | 2021-2025 | 781 | TW 4 | 53.04 |
| Renin-Angiotensin System Studies | 2021-2025 | 590 | TW 6 | 45.20 |
| Phytochemical Studies and Bioactivities | 2021-2025 | 516 | TW 10 | 44.32 |
| Ginkgo biloba and Cashew Applications | 2021-2025 | 845 | TW 3 | 33.12 |
| Chemotherapy-induced organ toxicity mitigation | 2021-2025 | 906 | TW 8 | 30.35 |
